McKesson Corporation provides pharmaceuticals and medical supplies in the United States and internationally. It operates in three segments: U.S. Pharmaceutical and Specialty Solutions, European Pharmaceutical Solutions, and Medical-Surgical Solutions. The company distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs, as well as other healthcare-related products; and offers practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices.
Read More…
Industry, Sector and Symbol
Industry Drugs, proprietaries, & sundries
Sub-IndustryHealth Care Distributors
SectorMedical
Phone972-446-4800
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$214.32 billion
Profitability
Miscellaneous
Employees80,000
Next Earnings Date10/24/2019 (Estimated)
OptionableOptionable
McKesson (NYSE:MCK) Frequently Asked Questions
What is McKesson's stock symbol?
McKesson trades on the New York Stock Exchange (NYSE) under the ticker symbol "MCK."
How often does McKesson pay dividends? What is the dividend yield for McKesson?
McKesson declared a quarterly dividend on Wednesday, July 31st. Shareholders of record on Tuesday, September 3rd will be given a dividend of $0.41 per share on Tuesday, October 1st. This represents a $1.64 dividend on an annualized basis and a yield of 1.13%. The ex-dividend date is Friday, August 30th. This is an increase from McKesson's previous quarterly dividend of $0.39. View McKesson's Dividend History.
How were McKesson's earnings last quarter?
McKesson Co. (NYSE:MCK) posted its quarterly earnings results on Wednesday, July, 31st. The company reported $3.31 EPS for the quarter, beating the Zacks' consensus estimate of $3.04 by $0.27. The business earned $55.73 billion during the quarter, compared to analysts' expectations of $54.03 billion. McKesson had a return on equity of 30.73% and a net margin of 0.27%. The firm's revenue for the quarter was up 5.9% on a year-over-year basis. During the same quarter in the prior year, the firm earned $2.90 earnings per share. View McKesson's Earnings History.
When is McKesson's next earnings date?
What guidance has McKesson issued on next quarter's earnings?
McKesson updated its FY20 earnings guidance on Wednesday, July, 31st. The company provided earnings per share guidance of $14.00-14.60 for the period, compared to the Thomson Reuters consensus estimate of $14.12.
What price target have analysts set for MCK?
9 Wall Street analysts have issued 1 year target prices for McKesson's stock. Their predictions range from $130.00 to $175.00. On average, they anticipate McKesson's share price to reach $149.2222 in the next twelve months. This suggests a possible upside of 3.0% from the stock's current price. View Analyst Price Targets for McKesson.
What is the consensus analysts' recommendation for McKesson?
9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for McKesson in the last year. There are currently 7 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for McKesson.
Has McKesson been receiving favorable news coverage?
Media coverage about MCK stock has trended positive this week, InfoTrie reports. The research group rates the sentiment of press coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. McKesson earned a coverage optimism score of 2.5 on InfoTrie's scale. They also gave press coverage about the company a news buzz of 6.0 out of 10, meaning that recent press coverage is somewhat likely to have an impact on the stock's share price in the near term. View News Stories for McKesson.
Are investors shorting McKesson?
McKesson saw a increase in short interest in July. As of July 15th, there was short interest totalling 4,773,500 shares, an increase of 8.4% from the June 15th total of 4,401,900 shares. Based on an average trading volume of 1,360,000 shares, the days-to-cover ratio is presently 3.5 days. Approximately 2.5% of the company's stock are sold short. View McKesson's Current Options Chain.
Who are some of McKesson's key competitors?
What other stocks do shareholders of McKesson own?
Who are McKesson's key executives?
McKesson's management team includes the folowing people:
- Mr. John H. Hammergren, Chairman & CEO (Age 60)
- Britt J. Vitalone, CFO & Exec. VP (Age 50)
- Ms. Lori A. Schechter, Chief Compliance Officer, Exec. VP & Gen. Counsel (Age 57)
- Mr. Jorge L. Figueredo, Exec. VP & Chief HR Officer (Age 58)
- Mr. Bansi Nagji, Exec. VP and Chief Strategy & Bus. Devel. Officer (Age 54)
Who are McKesson's major shareholders?
McKesson's stock is owned by many different of institutional and retail investors. Top institutional investors include Vanguard Group Inc. (8.70%), BlackRock Inc. (8.16%), BlackRock Inc. (8.16%), Invesco Ltd. (2.98%), Pzena Investment Management LLC (2.07%) and Baupost Group LLC MA (1.40%). Company insiders that own McKesson stock include Brian Scott Tyler, Britt J Vitalone, Erin M Lampert, John H Hammergren, Lori A Schechter, M Christine Jacobs and N Anthony Coles. View Institutional Ownership Trends for McKesson.
Which major investors are selling McKesson stock?
MCK stock was sold by a variety of institutional investors in the last quarter, including AQR Capital Management LLC, UBS Group AG, Van ECK Associates Corp, Baupost Group LLC MA, Ruffer LLP, Renaissance Technologies LLC, Quest Capital Management Inc. ADV and Vanguard Group Inc.. Company insiders that have sold McKesson company stock in the last year include Brian Scott Tyler, Britt J Vitalone, Lori A Schechter, M Christine Jacobs and N Anthony Coles. View Insider Buying and Selling for McKesson.
Which major investors are buying McKesson stock?
MCK stock was acquired by a variety of institutional investors in the last quarter, including Nuveen Asset Management LLC, Royal Bank of Canada, BlackRock Inc., BlackRock Inc., APG Asset Management N.V., Pzena Investment Management LLC, Price T Rowe Associates Inc. MD and Tavio Capital LLC. View Insider Buying and Selling for McKesson.
How do I buy shares of McKesson?
Shares of MCK can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is McKesson's stock price today?
One share of MCK stock can currently be purchased for approximately $144.85.
How big of a company is McKesson?
McKesson has a market capitalization of $26.78 billion and generates $214.32 billion in revenue each year. The company earns $34 million in net income (profit) each year or $13.57 on an earnings per share basis. McKesson employs 80,000 workers across the globe.View Additional Information About McKesson.
What is McKesson's official website?
How can I contact McKesson?
McKesson's mailing address is 6555 STATE HWY 161, IRVING TX, 75039. The company can be reached via phone at 972-446-4800 or via email at [email protected]
MarketBeat Community Rating for McKesson (NYSE MCK)
MarketBeat's community ratings are surveys of what our community members think about McKesson and other stocks. Vote "Outperform" if you believe MCK will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MCK will underperform the S&P 500 over the long term. You may vote once every thirty days.
